Who Owns vTv Therapeutics Stock?
NASDAQ: VTVTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 40.75%
- Held by insiders
- 38.83%
- Institutional holders
- 52
- Institutions 40.7%
- Insiders 38.8%
- Public and other 20.4%
Who owns vTv Therapeutics stock?
Institutional investors own about 40.7% of vTv Therapeutics's shares, spread across 52 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 38.83% of VTVT.
The largest institutional holders are Samsara BioCapital, LLC (7.58%), Millennium Management Llc (6.85%) and FMR, LLC (6.61%). Together, the top 10 institutions control 36.6% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their VTVT positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of VTVT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Samsara BioCapital, LLC | 298.50K | 7.58% | 0.0% |
| Millennium Management Llc | 269.87K | 6.85% | +30.8% |
| FMR, LLC | 260.39K | 6.61% | 0.0% |
| Siren, L.L.C. | 163.00K | 4.14% | 0.0% |
| Baker Bros. Advisors, LP | 148.31K | 3.77% | 0.0% |
| Vanguard Capital Management LLC | 94.46K | 2.40% | -13.3% |
| Trails Edge Capital Partners, LP | 85.19K | 2.16% | -39.0% |
| Aisling Capital Management LP | 50.00K | 1.27% | +100.0% |
| Marshall Wace LLP | 39.56K | 1.00% | +195.5% |
| Geode Capital Management, LLC | 32.47K | 0.82% | -1.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of VTVT
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 260.39K | 6.61% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 60.76K | 1.54% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 31.40K | 0.80% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 14.02K | 0.36% |
| iShares Trust-iShares Micro-Cap ETF | 7.19K | 0.18% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 4.78K | 0.12% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 4.19K | 0.11% |
| Invesco Exch-Trd Fd. TRT II-Invesco NASDAQ Future Gen 200 ETF | 3.35K | 0.09% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 2.52K | 0.06% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 1.52K | 0.04% |
Frequently asked questions
Who is the largest shareholder of vTv Therapeutics?
Samsara BioCapital, LLC is the largest institutional shareholder of VTVT, owning 7.58% of shares outstanding (298.50K shares) as of its latest 13F filing.
What percentage of vTv Therapeutics is owned by institutions?
Institutions own about 40.7% of VTVT shares and 66.6% of the public float.
How much of vTv Therapeutics do insiders own?
Insiders, such as officers and directors, own about 38.83% of VTVT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.